Literature DB >> 4034460

The clinical value of Haemoccult and Fecatwin in the detection of colorectal neoplasia in hospital and general practice patients.

I G Barrison, R A Parkins.   

Abstract

Four hundred and fifty asymptomatic general practice patients and 330 hospital inpatients had their stools tested for occult blood with the Haemoccult and Fecatwin methods. In general practice, 9/64 (14%) of patients with a positive result had a colonic neoplasm (three carcinomas, one Dukes' Stage A, two Dukes' Stage C, six adenomas) and in hospital 12/142 patients (8%) were found to have colonic tumours, (nine carcinomas, two Dukes' Stage A, two Dukes' Stage B, five Dukes' Stage C and three adenomas). The overall detection rates for colonic neoplasia were 2% in general practice and 3.4% in hospital. In 2 years of follow-up, none of the general practice patients have presented with colonic symptoms. Two hospital patients with colonic carcinomas produced negative tests with both methods. Out of the total of 21 colonic neoplasms, nine were detected by Fecatwin alone, but this trend in favour of the more sensitive test did not reach the 5% level of statistical significance. In contrast, the number of false positive results were significantly greater with Fecatwin than Haemoccult. From our data it would appear that the Fecatwin method warrants assessment in a full controlled trial of its value as a population screening test for colonic cancer.

Entities:  

Mesh:

Year:  1985        PMID: 4034460      PMCID: PMC2418350          DOI: 10.1136/pgmj.61.718.701

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  9 in total

1.  ASSESSMENT OF ROUTINE TESTS FOR OCCULT BLOOD IN FAECES.

Authors:  G ROSS; C H GRAY
Journal:  Br Med J       Date:  1964-05-23

Review 2.  Cancer of the colon and rectum--general aspects, diagnosis, treatment, and prognosis. A review.

Authors:  H H Scudamore
Journal:  Dis Colon Rectum       Date:  1969 Mar-Apr       Impact factor: 4.585

3.  Occult blood testing for detection of asymptomatic colon cancer.

Authors:  D H Greegor
Journal:  Cancer       Date:  1971-07       Impact factor: 6.860

4.  Diet and antibody response to vaccinations in healthy infants.

Authors:  G Zoppi; R Gasparini; F Mantovanelli; L Gobio-Casali; R Astolfi; P Crovari
Journal:  Lancet       Date:  1983-07-02       Impact factor: 79.321

5.  The Frome experiment--value of screening for colorectal cancer.

Authors:  P A Farrands; R L Griffiths; D C Britton
Journal:  Lancet       Date:  1981-06-06       Impact factor: 79.321

6.  Screening for occult gastrointestinal bleeding in hospital patients.

Authors:  I G Barrison; E R Littlewood; J Primavesi; A Sharples; I T Gilmore; R A Parkins
Journal:  J R Soc Med       Date:  1981-01       Impact factor: 5.344

7.  Faecal occult blood testing for colorectal cancer in general practice.

Authors:  R Million; J Howarth; E Turnberg; L A Turnberg
Journal:  Practitioner       Date:  1982-04

8.  The earlier detection of colorectal cancers: a preliminary report of the results of the Occult Blood Study.

Authors:  V A Gilbertsen; R McHugh; L Schuman; S E Williams
Journal:  Cancer       Date:  1980-06-01       Impact factor: 6.860

9.  Screening for asymptomatic bowel cancer in general practice.

Authors:  R C Lallemand; P A Vakil; P Pearson; V Box
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-07
  9 in total
  4 in total

1.  Prevention in family practice: Consensus statement from the front line.

Authors:  G Satenstein; J Lemelin; C Folkerson; K A Scott; W E Hogg
Journal:  Can Fam Physician       Date:  1991-10       Impact factor: 3.275

Review 2.  Colorectal carcinoma and Haemoccult. A study of its value in mass screening using meta-analysis.

Authors:  J Windeler; J Köbberling
Journal:  Int J Colorectal Dis       Date:  1987-11       Impact factor: 2.571

Review 3.  Screening for colorectal cancer: a critical review.

Authors:  J D Hardcastle; G Pye
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

4.  Chemical and immunological testing for faecel occult blood: a comparison of two tests in symptomatic patients.

Authors:  W M Thomas; J D Hardcastle; J Jackson; G Pye
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.